Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Deng Y, Diepstraten ST, Potts MA, Giner G, Trezise S, Ng AP, Healey G, Kane SR, Cooray A, Behrens K, Heidersbach A, Kueh AJ, Pal M, Wilcox S, Tai L, Alexander WS, Visvader JE, Nutt SL, Strasser A, Haley B, Zhao Q, Kelly GL, Herold MJ.
Deng Y, et al. Among authors: visvader je.
Nat Commun. 2022 Aug 12;13(1):4739. doi: 10.1038/s41467-022-32485-9.
Nat Commun. 2022.
PMID: 35961968
Free PMC article.